Since XIST was reported to be involved in NSCLC chemoresistance to DDP [23], we evaluated the expression of XIST in specimens from patients with or without previous DDP treatment, and in NSCLC cells exposed or not to DDP. This evidence concerns the gene XIST and non-small cell lung carcinoma.